WINDTREE THERAPEUTICS INC /DE/ Number of Reporting Units
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Number of Reporting Units of 100.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2025-04-15
- WINDTREE THERAPEUTICS INC /DE/ number of reporting units for the quarter ending 2023-03-31 was 100.00%, a 0.00% change year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ number of reporting units for the quarter ending 2022-03-31 was 100.00%, a 0.00% change year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ number of reporting units for the quarter ending 2021-03-31 was 100.00%.
- WINDTREE THERAPEUTICS INC /DE/ number of reporting units for fiscal 2024 was 100.00%, a 0.00% change from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ number of reporting units for fiscal 2023 was 100.00%, a 0.00% change from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ number of reporting units for fiscal 2022 was 100.00%, a 0.00% change from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ number of reporting units for fiscal 2021 was 100.00%, a 0.00% change from fiscal 2020.
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 6 month | Number of Reporting Units 9 month | Number of Reporting Units 12 month |
|---|---|---|---|---|
| 2024-12-31 | 100.00% 10-K · filed 2025-04-15 | |||
| 2023-12-31 | 100.00% 10-K · filed 2024-04-16 | |||
| 2023-09-30 | 100.00% 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | 100.00% 10-Q · filed 2023-08-07 | |||
| 2023-03-31 | 100.00% 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | 100.00% 10-K · filed 2023-03-31 | |||
| 2022-09-30 | 100.00% 10-Q · filed 2022-11-14 | |||
| 2022-03-31 | 100.00% 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | 100.00% 10-K · filed 2022-03-31 | |||
| 2021-09-30 | 100.00% 10-Q · filed 2021-11-10 | |||
| 2021-03-31 | 100.00% 10-Q · filed 2021-08-05 | |||
| 2020-12-31 | 100.00% 10-K · filed 2021-03-29 | |||
| 2019-12-31 | 100.00% 10-K · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |